MMP14 and triple-A syndrome: Although in opposition, a transgenic mouse harbouring a point mutation in the cytoplasmic domain MMP-14 (Y573D) which abrogates its signalling function without affecting its proteolytic activity, protected from Ang II-induced AAA development (128).